Further randomized controlled trials are needed to fully understand the efficacy and safety profiles of ECMO in SA/NFA. MP is being widely used to achieve safer ventilation, and although more data is required, it appears to be a promising option for evaluating the risk of developing VILI and the success of the therapy.
Keyphrases
- extracorporeal membrane oxygenation
- respiratory failure
- acute respiratory distress syndrome
- randomized controlled trial
- mechanical ventilation
- chronic obstructive pulmonary disease
- lung function
- electronic health record
- big data
- allergic rhinitis
- bone marrow
- meta analyses
- cystic fibrosis
- air pollution
- replacement therapy